ReleaseWire Connect

A state-of-the-art lab, with a focus on developing continuous purification technologies, that was inaugurated in November 2019 will be home to the first-of-a-kind continuous HPLC. Named "Kyoto Works," the 2,600m2 facility is owned by YMC in Fukuchiyama, near Kyoto, Japan.

Anyone faced with the challenges of isolating biomolecules such as mAbs, intact proteins, peptides, nucleotides, antibody drug conjugates (ADCs), or oligosaccharides, is also faced with the challenge of making the most optimal choice for their method and mode of separation.

CHIRAL ART Cellulose-SZ is a new chiral stationary phase recently launched by YMC. It is the seventh phase in the CHIRAL ART family of polysaccharide chiral phases for HPLC.

YMC has recently developed a YMC-Triart phase specifically designed for medium and large-scale purification of insulin and other peptides. This new stationary phase is described in a new technical flyer from YMC America.

The YMC product line for biomolecule separations is covered in a 24-page Bioseparation brochure, available for download below.

YMC-Triart is a well-established family of stationary phases for reversed-phase HPLC. The phases are based on an organic-inorganic hybrid silica particle and are available in pre-packed columns or bulk supply.

YMC America describes a size exclusion chromatography column in a 2-page brochure. The column is optimized for aggregates and fragments of monoclonal antibodies (mAb).

YMC Chiral columns include traditional Polysaccharide phases (Amylose and Cellulose) as well as Cyclodextrin phases and specialty chiral phases such as NEA and SumiChiral.

YMC-Triart recently published application information showing the successful separation of Diphenhydramine, Lidocaine, and 4-Isopropyl-3-methylphenol by reversed-phase.

YMC America describes Minichrom™ BioPro columns in a new two-page brochure. Minichrom™ BioPro columns are polypropylene LC columns packed with YMC BioPro IEX stationary phase material.